Business Context and Reporting Period
Palisade Bio, Inc. (PALI), a Delaware corporation, filed this Form 8-K on September 11, 2023, reporting events occurring on September 7, 2023. The filing details a registered direct offering of common stock and the execution of a placement agency agreement.
Key Financial Metrics and Transaction Details
- Offering Size: 2,339,398 shares of common stock.
- Price Per Share: $0.84.
- Gross Proceeds: Approximately $1.97 million.
- Placement Agent Fees: 7.75% of gross proceeds in cash, plus up to $95,000 for expenses.
- Placement Agent Warrants: 140,364 warrants (6.0% of shares sold) with a 5-year term and an exercise price of $1.05 per share.
- Net Proceeds: The filing does not provide a clear value for net proceeds after deducting fees and expenses.
Material Changes Versus Prior Period
This filing represents a discrete capital raise event rather than a periodic financial report. Consequently, there are no comparative revenue, profit, or margin metrics provided in this document. The primary material change is the increase in outstanding share count and the dilution associated with the issuance of new shares and placement agent warrants.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, operational outlook, or management commentary regarding future performance. The document includes standard risk disclosures noting that representations and warranties in the purchase agreements are for the benefit of the parties and may not reflect current facts or materiality standards for stockholders. The company utilized an effective shelf registration statement (File No. 333-263705) originally filed in March 2022.
Key Facts for Investor Verification
- Verify the exact number of shares outstanding post-closing to assess dilution impact.
- Confirm the total cash fees and expenses paid to the placement agent to calculate net proceeds accurately.
- Review the terms of the 140,364 placement agent warrants, specifically the $1.05 exercise price relative to the current market price.
- Check subsequent filings for the intended use of the $1.97 million in gross proceeds.